- Home
- COSM vs CLRB Comparison
COSM vs CLRB Comparison
Compare COSM & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- CLRB
- Stock Information
- Founded
- COSM 2009
- CLRB 2002
- Country
- COSM United States
- CLRB United States
- Employees
- COSM N/A
- CLRB N/A
- Industry
- COSM Other Pharmaceuticals
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- CLRB Health Care
- Exchange
- COSM Nasdaq
- CLRB Nasdaq
- Market Cap
- COSM 12.3M
- CLRB 14.2M
- IPO Year
- COSM 2013
- CLRB N/A
- Fundamental
- Price
- COSM $0.49
- CLRB $5.59
- Analyst Decision
- COSM
- CLRB Hold
- Analyst Count
- COSM 0
- CLRB 2
- Target Price
- COSM N/A
- CLRB N/A
- AVG Volume (30 Days)
- COSM 158.6K
- CLRB 167.7K
- Earning Date
- COSM 08-18-2025
- CLRB 08-12-2025
- Dividend Yield
- COSM N/A
- CLRB N/A
- EPS Growth
- COSM N/A
- CLRB N/A
- EPS
- COSM N/A
- CLRB N/A
- Revenue
- COSM $53,554,457.00
- CLRB N/A
- Revenue This Year
- COSM $28.14
- CLRB N/A
- Revenue Next Year
- COSM N/A
- CLRB N/A
- P/E Ratio
- COSM N/A
- CLRB N/A
- Revenue Growth
- COSM N/A
- CLRB N/A
- 52 Week Low
- COSM $0.28
- CLRB $4.36
- 52 Week High
- COSM $1.58
- CLRB $76.50
- Technical
- Relative Strength Index (RSI)
- COSM 58.83
- CLRB 42.91
- Support Level
- COSM $0.43
- CLRB $4.89
- Resistance Level
- COSM $0.50
- CLRB $5.33
- Average True Range (ATR)
- COSM 0.03
- CLRB 0.33
- MACD
- COSM 0.00
- CLRB 0.15
- Stochastic Oscillator
- COSM 87.95
- CLRB 79.04
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.